Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors

被引：31

作者：

Zbinden, KG ^{[1
]}

Obst-Sander, U ^{[1
]}

Hilpert, K ^{[1
]}

Kühne, H ^{[1
]}

Banner, DW ^{[1
]}

Böhm, HJ ^{[1
]}

Stahl, M ^{[1
]}

Ackermann, J ^{[1
]}

Alig, L ^{[1
]}

Weber, L ^{[1
]}

Wessel, HP ^{[1
]}

Riederer, MA ^{[1
]}

Tschopp, TB ^{[1
]}

Lavé, T ^{[1
]}

机构：

[1] F Hoffmann La Roche & Co Ltd, CH-4070 Basel, Switzerland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 23期

关键词：

D O I：

10.1016/j.bmcl.2005.04.079

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We describe the structure-based design and synthesis of highly potent, orally bioavailable tissue factor/factor Vila inhibitors which interfere with the coagulation cascade by selective inhibition of the extrinsic pathway. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：5344 / 5352

页数：9

共 50 条

[41] Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism
Hembrough, TA
Swartz, GM
Papathanassiu, A
Vlasuk, GP
Rote, WE
Green, SJ
Pribluda, VS
CANCER RESEARCH, 2003, 63 (11) : 2997 - 3000
[42] Tissue Factor in Brain Is Not Saturated With Factor VIIa Implications for Factor VIIa Dosing in Intracerebral Hemorrhage
Hoffman, Maureane
Monroe, Dougald M.
STROKE, 2009, 40 (08) : 2882 - 2884
[43] Protein Engineering and in Vitro Characterization of a Factor VIIa Analog with Selective Abrogation of Tissue Factor Binding
Gandhi, Prafull S.
Gron, Hanne
Petersen, Helle H.
Reedtz-Runge, Stine L.
Olsen, Ole H.
Ostergaard, Henrik
BLOOD, 2014, 124 (21)
[44] Tissue factor-dependent factor VIIa signaling
Petersen, LC
Freskgård, PO
Ezban, M
TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (02) : 47 - 52
[45] Current status on tissue factor activation of factor VIIa
Persson, Egon
Olsen, Ole H.
THROMBOSIS RESEARCH, 2010, 125 : S11 - S12
[46] Optimization of a series of potent, selective and orally bioavailable SYK inhibitors
Grimster, Neil P.
Gingipalli, Lakshmaiah
Barlaam, Bernard
Su, Qibin
Zheng, XiaoLan
Watson, David
Wang, Haixia
Simpson, Iain
Pike, Andy
Balazs, Amber
Boiko, Scott
Ikeda, Timothy P.
Impastato, Anna C.
Jones, Natalie H.
Kawatkar, Sameer
Kemmitt, Paul
Lamont, Scott
Patel, Joe
Read, Jon
Sarkar, Ujjal
Sha, Li
Tomlinson, Ronald C.
Wang, Haiyun
Wilson, David M.
Zehnder, Troy E.
Wang, Lianghe
Wang, Peng
Goldberg, Frederick W.
Shao, Wenlin
Fawell, Stephen
Dry, Hannah
Dowling, James E.
Edmondson, Scott D.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (19)
[47] THE INTERACTION OF HUMAN FACTOR-VIIA WITH TISSUE FACTOR
KRISHNASWAMY, S
JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (33) : 23696 - 23706
[48] Neutral macrocyclic factor VIIa inhibitors
Wurtz, Nicholas R.
Parkhurst, Brandon L.
DeLucca, Indawati
Glunz, Peter W.
Jiang, Wen
Zhang, Xiaojun
Cheney, Daniel L.
Bozarth, Jeffrey M.
Rendina, Alan R.
Wei, Anzhi
Harper, Tim
Luettgen, Joseph M.
Wu, Yiming
Wong, Pancras C.
Seiffert, Dietmar A.
Wexler, Ruth R.
Priestley, E. Scott
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (12) : 2650 - 2654
[49] Benzylamine-based selective and orally bioavailable inhibitors of thrombin
Lee, K
Jung, WH
Park, CW
Hong, CY
Kim, IC
Kim, S
Oh, YS
Kwon, OH
Lee, SH
Park, HD
Kim, SW
Lee, YH
Yoo, YJ
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (18) : 2563 - 2568
[50] The quest for factor VIIa exosite inhibitors
Amour, A.
Hutchinson, J.
Avendano, A. M. Ruiz
Ratcliffe, S.
Alvarez, E.
Martin, J.
Toomey, J. R.
Senger, S.
Wolfeni, M.
Mooney, C.
BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 555 - 558

← 1 2 3 4 5 →